Burden of ischemic stroke attributable to high low-density lipoprotein cholesterol in China from the global burden of disease study 2021

Abstract High low-density lipoprotein cholesterol are a significant risk factor for ischemic stroke. This study aims to analyze the burden of disease and temporal trends of ischemic stroke attributable to high LDL-C (IS-hLDL-C) in China, thereby providing a scientific basis for the development of ef...

Full description

Saved in:
Bibliographic Details
Main Authors: Hua Xue, Yuqi Zeng, Xinyang Zou, Yanhong Jiang, Wenhui Fan, Yongkun Li
Format: Article
Language:English
Published: Nature Portfolio 2025-06-01
Series:Scientific Reports
Subjects:
Online Access:https://doi.org/10.1038/s41598-025-04677-y
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850136649506226176
author Hua Xue
Yuqi Zeng
Xinyang Zou
Yanhong Jiang
Wenhui Fan
Yongkun Li
author_facet Hua Xue
Yuqi Zeng
Xinyang Zou
Yanhong Jiang
Wenhui Fan
Yongkun Li
author_sort Hua Xue
collection DOAJ
description Abstract High low-density lipoprotein cholesterol are a significant risk factor for ischemic stroke. This study aims to analyze the burden of disease and temporal trends of ischemic stroke attributable to high LDL-C (IS-hLDL-C) in China, thereby providing a scientific basis for the development of effective prevention and intervention strategies. This study extracted the age-standardized mortality rates (ASMRs) and age-standardized disability-adjusted life years rates (ASDRs) of IS-hLDL-C from the global burden of disease (GBD) 2021. Stratified analysis was performed by gender and age groups. Joinpoint regression models were used to calculate average annual percentage changes (AAPC) to assess trends in IS-hLDL-C burden between 1990 and 2021. Age-period-cohort (APC) model to estimate the independent effects of age, period, and cohort on IS-hLDL-C burden. In 2021, the total number of IS-hLDL-C deaths in China was 300,052 (95% UI 92,515–527,456), and disability-adjusted life years (DALYs) was 6,850,565 (95% UI 2,313,203 − 11,418,167). From 1990 to 2021, ASMRs changed from 18.23 (95% CI 5.52–33.43) to 15.93 (95% CI 4.83–28.08), and the AAPC was −0.47 (95% CI −0.83 to −0.10). The ASDRs decreased from 385.65 (95% CI 129.83 to 647.51) in 1990 to 335.59 (95% CI 112.75 to 566.25) in 2021, with an AAPC of −0.49 (95% CI −0.83 to −0.10). Sex-stratified analysis showed that male had greater ASMRs and ASDRs than female. Age-stratified analysis showed that the burden was greatest among the elderly. In the age-period-cohort analysis, the age effect of IS-hLDL-C showed a continuous increasing trend during the study period. The period effect generally showed a positive trend during the study period. From 1990 to 2021, while the ASMRs and ASDRs related to IS-hLDL-C have decreased in China, the absolute numbers of deaths and DALYs remain substantial. The burden of IS-hLDL-C disease is disproportionately higher among male and the elderly. Given large population and the ongoing trend of population aging, it is essential to consider various lipid-lowering strategies in the future to allocate healthcare resources effectively and reduce the disease burden associated with IS-hLDL-C.
format Article
id doaj-art-705edac7c10e4362abd3c01d9cbbd12e
institution OA Journals
issn 2045-2322
language English
publishDate 2025-06-01
publisher Nature Portfolio
record_format Article
series Scientific Reports
spelling doaj-art-705edac7c10e4362abd3c01d9cbbd12e2025-08-20T02:31:04ZengNature PortfolioScientific Reports2045-23222025-06-0115111110.1038/s41598-025-04677-yBurden of ischemic stroke attributable to high low-density lipoprotein cholesterol in China from the global burden of disease study 2021Hua Xue0Yuqi Zeng1Xinyang Zou2Yanhong Jiang3Wenhui Fan4Yongkun Li5Department of Neurology, Shengli Clinical Medical College of Fujian Medical UniversityDepartment of Neurology, Fujian Medical University Union HospitalDepartment of Neurology, Shengli Clinical Medical College of Fujian Medical UniversityDepartment of Neurology, Sichuan Taikang HospitalDepartment of Neurology, Sichuan Taikang HospitalDepartment of Neurology, Shengli Clinical Medical College of Fujian Medical UniversityAbstract High low-density lipoprotein cholesterol are a significant risk factor for ischemic stroke. This study aims to analyze the burden of disease and temporal trends of ischemic stroke attributable to high LDL-C (IS-hLDL-C) in China, thereby providing a scientific basis for the development of effective prevention and intervention strategies. This study extracted the age-standardized mortality rates (ASMRs) and age-standardized disability-adjusted life years rates (ASDRs) of IS-hLDL-C from the global burden of disease (GBD) 2021. Stratified analysis was performed by gender and age groups. Joinpoint regression models were used to calculate average annual percentage changes (AAPC) to assess trends in IS-hLDL-C burden between 1990 and 2021. Age-period-cohort (APC) model to estimate the independent effects of age, period, and cohort on IS-hLDL-C burden. In 2021, the total number of IS-hLDL-C deaths in China was 300,052 (95% UI 92,515–527,456), and disability-adjusted life years (DALYs) was 6,850,565 (95% UI 2,313,203 − 11,418,167). From 1990 to 2021, ASMRs changed from 18.23 (95% CI 5.52–33.43) to 15.93 (95% CI 4.83–28.08), and the AAPC was −0.47 (95% CI −0.83 to −0.10). The ASDRs decreased from 385.65 (95% CI 129.83 to 647.51) in 1990 to 335.59 (95% CI 112.75 to 566.25) in 2021, with an AAPC of −0.49 (95% CI −0.83 to −0.10). Sex-stratified analysis showed that male had greater ASMRs and ASDRs than female. Age-stratified analysis showed that the burden was greatest among the elderly. In the age-period-cohort analysis, the age effect of IS-hLDL-C showed a continuous increasing trend during the study period. The period effect generally showed a positive trend during the study period. From 1990 to 2021, while the ASMRs and ASDRs related to IS-hLDL-C have decreased in China, the absolute numbers of deaths and DALYs remain substantial. The burden of IS-hLDL-C disease is disproportionately higher among male and the elderly. Given large population and the ongoing trend of population aging, it is essential to consider various lipid-lowering strategies in the future to allocate healthcare resources effectively and reduce the disease burden associated with IS-hLDL-C.https://doi.org/10.1038/s41598-025-04677-yIschemic strokeHigh low-density lipoprotein cholesterolChinaJoinpoint regression modelsDisability adjusted life year
spellingShingle Hua Xue
Yuqi Zeng
Xinyang Zou
Yanhong Jiang
Wenhui Fan
Yongkun Li
Burden of ischemic stroke attributable to high low-density lipoprotein cholesterol in China from the global burden of disease study 2021
Scientific Reports
Ischemic stroke
High low-density lipoprotein cholesterol
China
Joinpoint regression models
Disability adjusted life year
title Burden of ischemic stroke attributable to high low-density lipoprotein cholesterol in China from the global burden of disease study 2021
title_full Burden of ischemic stroke attributable to high low-density lipoprotein cholesterol in China from the global burden of disease study 2021
title_fullStr Burden of ischemic stroke attributable to high low-density lipoprotein cholesterol in China from the global burden of disease study 2021
title_full_unstemmed Burden of ischemic stroke attributable to high low-density lipoprotein cholesterol in China from the global burden of disease study 2021
title_short Burden of ischemic stroke attributable to high low-density lipoprotein cholesterol in China from the global burden of disease study 2021
title_sort burden of ischemic stroke attributable to high low density lipoprotein cholesterol in china from the global burden of disease study 2021
topic Ischemic stroke
High low-density lipoprotein cholesterol
China
Joinpoint regression models
Disability adjusted life year
url https://doi.org/10.1038/s41598-025-04677-y
work_keys_str_mv AT huaxue burdenofischemicstrokeattributabletohighlowdensitylipoproteincholesterolinchinafromtheglobalburdenofdiseasestudy2021
AT yuqizeng burdenofischemicstrokeattributabletohighlowdensitylipoproteincholesterolinchinafromtheglobalburdenofdiseasestudy2021
AT xinyangzou burdenofischemicstrokeattributabletohighlowdensitylipoproteincholesterolinchinafromtheglobalburdenofdiseasestudy2021
AT yanhongjiang burdenofischemicstrokeattributabletohighlowdensitylipoproteincholesterolinchinafromtheglobalburdenofdiseasestudy2021
AT wenhuifan burdenofischemicstrokeattributabletohighlowdensitylipoproteincholesterolinchinafromtheglobalburdenofdiseasestudy2021
AT yongkunli burdenofischemicstrokeattributabletohighlowdensitylipoproteincholesterolinchinafromtheglobalburdenofdiseasestudy2021